和铂医药-B11月13日斥资270.11万港元回购20万股

Core Viewpoint - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Categories Share Buyback Details - The company will repurchase 200,000 shares at a total cost of HKD 2.7011 million [1] - The buyback price per share ranges from HKD 13.24 to HKD 13.67 [1]